Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiplex networks-based directed graph neural network for cancer driver gene identification.

PLoS computational biology·2026
Same author

The efficacy of psychosocial interventions in relieving family caregiver burden in older adults with disabilities: a systematic review and network meta-analysis.

Age and ageing·2025
Same author

Comparing Narrative and Visual Arts for Empathy Enhancement in Nursing Postgraduate Education: A Mixed Method Study.

Journal of continuing education in nursing·2025
Same author

Restless Legs Syndrome in Hemodialysis Patients: Clinical and Electrophysiological Study.

Journal of multidisciplinary healthcare·2024
Same author

Multi-view contrastive clustering for cancer subtyping using fully and weakly paired multi-omics data.

Methods (San Diego, Calif.)·2024
Same author

DrugDoctor: enhancing drug recommendation in cold-start scenario via visit-level representation learning and training.

Briefings in bioinformatics·2024

Related Experiment Video

Updated: May 21, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K

DriverMEDS: Cancer driver gene identification using mutual exclusivity from embeded features and driver mutation

Sichen Yi1, Minzhu Xie2

  • 1Key Laboratory of Computing and Stochastic Mathematics (Ministry of Education), School of Mathematics and Statistics, Hunan Normal University, Changsha 410081, China.

Methods (San Diego, Calif.)
|March 20, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces DriverMEDS, a new computational framework for identifying cancer driver genes by analyzing gene function networks and mutation data. DriverMEDS improves cancer diagnosis and treatment by uncovering novel driver genes and their associated functional modules.

Keywords:
Cancer driverClustering algorithmEmbedded featuresMutual exclusivity

More Related Videos

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.4K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K

Related Experiment Videos

Last Updated: May 21, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.4K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K

Area of Science:

  • Computational biology
  • Genomics
  • Cancer research

Background:

  • Identifying cancer driver genes is crucial for cancer development, diagnosis, and treatment.
  • Current methods often integrate multi-omics data and network embedding but overlook mutual exclusivity in the embedding space and assume high mutation frequencies for all driver genes.

Purpose of the Study:

  • To develop an unsupervised framework, DriverMEDS, that leverages mutual exclusivity within learned gene features and optimizes mutation frequency scoring for improved cancer driver gene identification.

Main Methods:

  • DriverMEDS utilizes a feature clustering algorithm to create gene modules, calculating module importance scores based on Euclidean distances of learned features and mutual exclusivity.
  • A novel driver mutation scoring function is introduced, considering that most driver genes exhibit intermediate mutation frequencies.
  • Gene prioritization is achieved through a weighted sum of module importance and driver mutation scores.

Main Results:

  • DriverMEDS successfully detected novel cancer driver genes and relevant functional modules.
  • Experimental analysis demonstrated that DriverMEDS outperforms five state-of-the-art methods for cancer driver identification.

Conclusions:

  • DriverMEDS offers a more effective approach to unsupervised cancer driver gene identification by incorporating mutual exclusivity in the embedding space and refining mutation frequency analysis.
  • The framework has the potential to advance cancer diagnosis and treatment strategies.